PRESS RELEASE published on 08/27/2026 at 18:59, 1 month 20 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma révèle un chiffre d’affaires consolidé de 1,9 M€ et une trésorerie de 26,9 M€ au 30 juin 2026. La société biopharmaceutique annonce des résultats financiers et une avancée dans le développement de thérapies innovantes Chiffre D'affaires Développement Trésorerie ABIONYX Pharma Thérapies Innovantes
PRESS RELEASE published on 08/27/2026 at 18:59, 1 month 20 days ago Inside Information / Other news releases ABIONYX Pharma updates activity and cash position for H1 2026: revenue of €1.9M, cash balance of €26.9M before Research Tax Credits and grants. Company focuses on innovative therapies for sepsis Revenue Cash Position Innovative Therapies ABIONYX Pharma Activity Update
BRIEF published on 07/06/2026 at 20:05, 3 months 10 days ago ABIONYX Monthly Voting Rights Update Euronext Paris Share Capital Voting Rights Financial Update ABIONYX Pharma
BRIEF published on 07/06/2026 at 20:05, 3 months 10 days ago ABIONYX : Détails sur le Capital Social et les Droits de Vote Euronext Paris Droits De Vote Capital Social AMF ABIONYX
BRIEF published on 07/06/2026 at 20:05, 3 months 10 days ago ABIONYX: Details on Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 07/06/2026 at 20:05, 3 months 10 days ago Mise à jour mensuelle d'ABIONYX sur les droits de vote Euronext Paris Capital Social Droit De Vote Mise À Jour Financière ABIONYX Pharma
PRESS RELEASE published on 07/06/2026 at 20:00, 3 months 10 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique les informations sur son capital social et ses droits de vote, avec 42 568 071 actions en circulation le 30 juin 2026 Droits De Vote Développement Capital Social Biopharma ABIONYX Pharma
PRESS RELEASE published on 07/06/2026 at 20:00, 3 months 10 days ago Inside Information / Other news releases ABIONYX Pharma discloses monthly statement of total voting rights and shares. Company focuses on innovative medicines development with lipid science expertise Shares Total Voting Rights ABIONYX Pharma Innovative Medicines Lipid Science
BRIEF published on 07/06/2026 at 19:19, 3 months 10 days ago ABIONYX's Half-Yearly Review of the Liquidity Contract Liquidity Transactions TP ICAP Actions ABIONYX Pharma
BRIEF published on 07/06/2026 at 19:19, 3 months 10 days ago Bilan semestriel du contrat de liquidité d'ABIONYX Transactions TP ICAP Actions Liquidité ABIONYX Pharma
Published on 10/17/2026 at 03:20, 8 hours 25 minutes ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 8 hours 30 minutes ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 12 hours 10 minutes ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 12 hours 15 minutes ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 12 hours 45 minutes ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/16/2026 at 20:08, 15 hours 37 minutes ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 16 hours 25 minutes ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:05, 16 hours 40 minutes ago Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers
Published on 10/16/2026 at 18:18, 17 hours 27 minutes ago Issue Price of Placing and WRAP Retail Offer
Published on 10/16/2026 at 18:13, 17 hours 32 minutes ago EQS-Adhoc: DHL AG: DHL AG raises full-year 2026 earnings guidance
Published on 10/16/2026 at 19:54, 15 hours 51 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 16 hours 57 minutes ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 16 hours 57 minutes ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 17 hours 45 minutes ago KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026
